20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9232 | Mitochondrial fusion promoter M1 | Mitochondrial Metabolism | |
Mitochondrial fusion promoter M1, a modulator of mitochondrial dynamics, enhances mitochondrial function and cellular respiration, and has shown efficacy in reducing brain and cardiac damage in rats suffering from cardia... | |||
T21793 | CGP 35348 | GABA Receptor | |
CGP 35348 is a selective antagonist of GABAB receptor (EC50 = 34 μM). CGP 35348 can be used in studies of neuromuscular coordination and spatial learning after neonatal brain damage in albino mice. | |||
T9776 | TRPM4 inhibitor 8 | TRP/TRPV Channel | |
TRPM4 inhibitor 8 is an inhibitor of Transient receptor potential melastatin 4(TRPM4) which contributes to viability, migration, cell cycle shift, and adhesion. | |||
T70470L | Isomer-CM 352 | isomer-1542205-83-3 | MMP |
isomer-CM 352 is a metalase inhibitor that can be used to slow brain damage. | |||
T4S1725 | Galanthamine | Galantamine | Apoptosis , AChE |
Galanthamine (Galantamine) is an acetylcholinesterase (AChE)inhibitor(IC50 : 500 nM), can reduce brain damage induced by hypoxia-ischemia. | |||
T28607 | Rocepafant | LAU 8080,LAU8080,BN 50730,LAU-8080,BN50730,BN-50730 | Platelet aggregation |
Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.Rocepafant inhibits tumor necrosis factor-Afa-mediated cytotoxicity in mouse L929 tumor... | |||
T70470 | CM-352 | MMP | |
CM-352 is a metalloproteinase inhibitor that reduces brain damage and improves functional recovery in rat models of cerebral hemorrhage. | |||
T3414 | Morroniside | Apoptosis , MMP , Pyroptosis | |
Morroniside would act as a regulator of hepatic inflammatory reactions and lipid metabolism in db/db mice. It exhibits protective effects against diabetic renal damage and human umbilical vein endothelial cells, by inhib... | |||
T5S0636 | Citric acid | Citro,Citretten | Apoptosis , Others , Endogenous Metabolite , Antibacterial , Antibiotic |
1. Citric acid (Citro) (1-2 g/kg) can decrease brain lipid peroxidation and inflammation, liver damage, and DNA fragmentation. 2. Citric acid denture cleansers can reduce C. albicans biofilm accumulation and cell viabili... | |||
T32098L | Homocarnosine acetate | GABA Receptor , Endogenous Metabolite | |
Homocarnosine acetate is a dipeptide unique to brain consisting of γ-aminobutyric acid (GABA) and histidine. Homocarnosine acetate has antioxidant and anti-inflammatory actions, prevention of DNA damage, and inhibition o... | |||
T73599 | TSPO ligand-1 | Autophagy | |
TSPO ligand-1 has affinity for peripheral and central benzodiazepine receptors.TSPO ligand-1 is an AUTAC4-binding protein in the transmembrane domain of the outer mitochondrial membrane, which induces mitochondrial autop... | |||
T3S1729 | Dihydrolycorine | Others | |
1. Dihydrolycorine-HCL(DL) shows hypotensive effects, it can block alpha 1-adrenoceptors. 2. Dihydrolycorine is an inhibitors of protein synthesis in eukarytic cells, it halts protein synthesis in eukaryotic cells by inh... | |||
T5232 | 3-Methyl-2-oxobutanoic acid | 2-Oxoisovaleric acid,alpha-Ketoisovaleric acid | Others , Endogenous Metabolite |
3-Methyl-2-oxobutanoic acid (2-Oxoisovaleric acid) is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. 3-Methyl-2-oxobutanoic acid is a neurotoxin, an acidogen, and a metabo... | |||
T72662 | NMDAR/TRPM4-IN-2 | ERK , TRP/TRPV Channel , NMDAR , iGluR | |
NMDAR/TRPM4-IN-2 is a potent interfacial inhibitor of NMDAR/TRPM4 interaction.NMDAR/TRPM4-IN-2 protects against MCAO-induced brain damage and NMDA-induced retinal ganglion cell loss in mice.NMDAR/TRPM4-IN-2 has neuroprot... | |||
T38063 | N-Acetyl lysyltyrosylcysteine amide | Glutathione Peroxidase | |
N-Acetyl lysyltyrosylcysteine amide is a non-toxic myeloperoxidase (MPO) tripeptide inhibitor that is potent, reversible, and specific.N-Acetyl lysyltyrosylcysteine amide effectively inhibits MPO production in vivo. N-Ac... | |||
T61268 | Vutiglabridin | HSG4112 | Phosphatase |
Vutiglabridin (HSG4112) is a novel and safe modulator of PON2, a racemic compound. vutiglabridin is an optimized structural analogue of Glabridin and is superior to Glabridin in terms of weight loss and chemical stabilit... | |||
T25722 | Lifarizine methanesulfonate | ||
Lifarizine methanesulfonate is a modulator of sodium-calcium channel that reduces ischemic brain damage. | |||
T27959 | LY503430 | LY-503430,LY 503430 | |
LY503430 is a AMPA receptor potentiator with oral activity. LY503430 has both nootropic and neuroprotective effects, reducing brain damage caused by 6-hydroxydopamine or MPTP. | |||
T70838 | RO27-3225 TFA | ||
RO27-3225, also known as RO273225 is a melanocortin type 4 receptor agonist with EC50 = 1 nM. It may alleviate intestinal dysfuntion and brain damage. It has been investigated for an anti-obesity medication. Ro 27-3225... | |||
T26627 | Anatibant | LF16-0687,LF-16-0687,LF 160687,LF 16-0687,LF-160687 | |
Anatibant is a potent non-peptide bradykinin B2 receptor antagonist. Anatibant reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury. |